Dexcom CGM use is proven to improve glycemic control 1,2   and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British Columbia --(BUSINESS WIRE)--Jun. 11, 2021-- Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous

Results of two new studies illustrate continued momentum for Dexcom CGM, including JAMA-published data on additional populations who can benefit from the technology SAN DIEGO --(BUSINESS WIRE)--Jun. 3, 2021-- DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring

Dexcom CGM use is proven to improve glycemic control 1,2  and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, BC , June 1, 2021 /CNW Telbec/ - Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring

SAN DIEGO --(BUSINESS WIRE)--May 27, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Jereme Sylvain , Executive Vice President and Chief Financial Officer, will present on behalf of the company at the

Proven to improve glycemic control and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 1 BURNABY, BC , May 26, 2021 /CNW Telbec/ - Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that

SAN DIEGO --(BUSINESS WIRE)--Apr. 29, 2021-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2021 . First Quarter 2021 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $505.0 million U.S.

Dexcom G6 gives people with diabetes the power to manage their condition without fingersticks* or scanning Proven to improve glycemic control and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring 1 BURNABY, BC , April 20, 2021 /CNW/ - Dexcom

Dexcom G6 gives people with diabetes the power to manage their condition without fingersticks* or scanning BURNABY, BC , April 16, 2021 /CNW/ - Dexcom , Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), is pleased to see that the governments of Saskatchewan and

Dexcom is now directly selling the Dexcom G6 Continuous Glucose Monitoring (CGM) System across the Netherlands Dexcom G6 CGM means no more fingersticks * for people with diabetes Real-time glucose data sent wirelessly to a compatible smart device † or Dexcom receiver Customisable alerts and alarms

SAN DIEGO --(BUSINESS WIRE)--Apr. 1, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, April 29, 2021 . Management will hold a conference call to review the company's first quarter 2021 performance